ALKBH5 and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma (ICC), ALKBH5 regulates the tumor immune microenvironment and immunotherapeutic efficacy via modulating the methylation of PD-L1 mRNA [18–20].